| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.6 |